1. Home
  2. CNMD vs HROW Comparison

CNMD vs HROW Comparison

Compare CNMD & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CONMED Corporation

CNMD

CONMED Corporation

N/A

Current Price

$51.52

Market Cap

985.5M

Sector

Health Care

ML Signal

N/A

HROW

Harrow Inc.

N/A

Current Price

$26.59

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNMD
HROW
Founded
1970
1998
Country
United States
United States
Employees
N/A
373
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
985.5M
1.0B
IPO Year
1995
2008

Fundamental Metrics

Financial Performance
Metric
CNMD
HROW
Price
$51.52
$26.59
Analyst Decision
Hold
Strong Buy
Analyst Count
7
9
Target Price
$46.83
★ $63.00
AVG Volume (30 Days)
422.7K
★ 582.5K
Earning Date
10-28-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 71.43
EPS
★ 1.87
N/A
Revenue
★ $1,374,724,000.00
N/A
Revenue This Year
N/A
$28.41
Revenue Next Year
$4.73
$58.14
P/E Ratio
$28.70
★ N/A
Revenue Growth
★ 5.18
N/A
52 Week Low
$31.44
$26.96
52 Week High
$53.73
$54.98

Technical Indicators

Market Signals
Indicator
CNMD
HROW
Relative Strength Index (RSI) 60.66 34.95
Support Level $43.21 N/A
Resistance Level $53.09 $30.28
Average True Range (ATR) 2.39 1.29
MACD 0.64 0.05
Stochastic Oscillator 70.31 18.92

Price Performance

Historical Comparison
CNMD
HROW

About CNMD CONMED Corporation

Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: